1 |
Garzon R, Volinia S, Liu CC, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, Flomenberg N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreeff M, Croce CM. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. The American Society of Hematology. 2008; 111(6): 3183-89.
|
2 |
Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. The microRNA spectrum in 12 body fluids. Clin Chem. 2010; 56(11): 1733-41.
DOI
|
3 |
Park JH, Go M. Effect of Allregen Remover Rhus Verniciflua Extract on Inhibition of Tumor Metastasis. Kor J Traditional Oncology. 2010; 15(1): 47-61.5(1): 47-61.
|
4 |
Eom SK. Disease Recognition of Tumor, Bump or Mass entil Han Dynasty. Kor J Medical Classics. 2008; 21(2): 29-37.
|
5 |
Yoon SW, Park JW, Kim KS, Jung HS, Choi WC. The study on the Safety and Case Series of the Acute Lymphocytic Leukemia using Rhus Verniciflua Stokes Extract(Nexia). Kor J Oriental Oncology. 2006; 11(1): 1-21.
|
6 |
Park JH, Eum SK, Cheong GS, Kim KS, Yun SW, Choi WC. Bridf review about tumor pathology and etiology focusssed on JIJU. Kor J Oriental Oncology. 2007; 12(1): 1-13.
|
7 |
Lee SH, Jo JG. Literature review on metastasis and growth inhibition of cancer using ‘the activation and the elimination of blood stasis’. Journal of Haehwa Medicine. 1998; 7(1): 699-710.
|
8 |
Professors of Herval medicine in National College of Korean Medicine. Herbology. Yonglimsa. 1991; 439.
|
9 |
Shin MK. Clinical Transitional Herbology. Yonglimsa. 2010; 233-236.
|
10 |
Lim KT, Hu C, Kitts DD. Antioxidant activity of Rhus verniciflua stokes ethanol extract. Food Chem Toxicol. 2001; 39(3): 229-237.
DOI
|
11 |
Oh SH. Anti-inflammatory effects of Rhus Vernicifera Stokes extract in LPS-induced macrophage RAQ264.7 cells. Kyungwon University PhD Thesis. 2006; 16-25.
|
12 |
Park KY, Jung GO, Lee KT, Choi J, Choi MY, Kim GT, Jung HJ, Park HJ. Antimutagenic activity of glavonoids from the heartwood of Rhus verniciflua. J. Ethnopharmacol. 2004; 90(1): 73-79.
DOI
|
13 |
Kim JH, Kim HP, Jung CH, Hong MH, Hong MC, Lee SD, Park SY, Park JH, Ko SG. Inhibition of cell cycle progression via p27Kip1 upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua stokes in AGS gastric cancer cells. Int. J. Mol. Med. 2006; 18(1): 201-208.
|
14 |
Choi WC, Lee JH, Lee EO, Yoon SW, Ahn KS, Kim SH. Study on antiangiogenic and antitumor activities of processed Rhus verniciflua stokes extract. Kor J Oriental Physiology & Pathology. 2006; 20: 825-829.
|
15 |
Hwang JH. Pancreatic cancer and miRNAs. Kor J Gastroenterol. 2012; 59(6): 395-400.
DOI
|
16 |
Fabbri M, Croce CM, Calin GA. MicroRNAs. J Cancer. 2008; 14(1): 1-6.
DOI
|
17 |
Davis-Dusenbery BN, Hata A. Mechanisms of control of microRNA biogenesis. J biochemistry. 2010; 148: 381-392.
|
18 |
Lee RC, Feinbaum RL, Ambrous V. The elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75: 843-854.
DOI
|
19 |
Park SJ, Kim KS, Jung HS, Choi WC, Yoon SW. The Study on the Process and Quality Control of Rhus Verniciflua Stokes Extract(Nexia). Kor J Oriental Oncology. 2006; 11(1): 31-39.
|
20 |
Bai Y, Liao H, Liu T, Zeng X, Xial F, LuoL, GuoH, Guo L. MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-a-go-go(EAG1). Eur J Cancer , 2013; 49: 710-724
DOI
|
21 |
Mojca Jongen-Lavrencic, Sun SM, Dijkstra MK, Valk PJM, Lowenberg B. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. The American Society of Hematology. 2008; 111(10): 5078-85.
|
22 |
Mi S, Lu J, Sun M, Li Z, Zhang H, Neilly MB, Wang Y, Qian Z, Jin J, Zhang Y, Bohlander SK, Le Beau MM, Larson RA, Golub TR, Rowley JD, Chen J. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myelod leukemia. Proc Natl Acad Sci USA. 2007; 104(50): 19971-76.
DOI
|
23 |
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007; 131(6): 1109-23.
DOI
|
24 |
Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, Papotti M, Allgayer H. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res. 2010; 8(9): 1207-16.
DOI
|
25 |
Akao Y, Nakagawa Y, Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep. 2006; 16(4): 845-850.
|
26 |
Salvatori B, Iosue I, Djodji Damas N, Mangiavacchi A, Chiaretti S, Messina M, Padula F, Guarini A, Bozzoni I, Fazi F, Fatica A. Critical Role of c-Myc in Acute Myeloid Leukemia involving Direct Regulation of miR-26a abd Histone Methyltransferase EZH2. Genes Cancer. 2011; 2(5): 585-592.
DOI
|
27 |
Salvatori B, losue I, Mangiavacchi A, Loddo G, Padula F, Chiaretti S, Peragine N, Bozzoni I, Fazi F, Fatica A. The micreRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells. Cell Death and Disease. 2012; 25(3): 1-10.
|
28 |
Shan Y, Zhang L, Bao Y, Li B, He C, Gao M, Feng X, Xu W, Zhang X, Wang S. Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. J Nutr Biochem. 2013; 1062-69.
DOI
|
29 |
Hurteau GJ, Carlson JA, Spivack SD. Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007; 67(17): 7972-76.
DOI
|
30 |
Chen ML, Liang LS, Wang XK. miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1. Clin Exp Metastasis. 2012; 29(5): 457-469.
DOI
|
31 |
Shenouda SK, Alahari SK. MicroRNA function in cancer: oncogene or tumor suppressor? Cancer Metastasis Rev. 2009; 28: 369-378.
DOI
|
32 |
Agirre X, Vilas-Zornoza A, Jimenez-Velasco A, Martin-Subero JI, Cordeu L, Garate L, San Jose-Eneriz E, Abizanda G, Rodriguez-Otero P, Fortes P, Rifon J, Bandres E, Calasanz MJ, Martin V, Heiniger A, Torres A, Siebert R, Roman-Gomez J, Prosper F. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res. 2009; 69(10): 4443-53.
DOI
|